cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling Heavy-chain antibody targeting of CD38
Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target Nicotinamide N methyltransferase inhibition mimics and boosts exercise mediated improvements in muscle function in aged mice Scientific Reports Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect
Pay in 4 interest-free payments of $7.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




